0
2022
Neurothrombectomy Devices Market

Neurothrombectomy devices Market

by Product Type (Clot Retrieval Devices, Aspiration Devices, Snares), by End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A16940
Jun 2022 | Pages: 206
Tables: 111
Charts: 54
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Neurothrombectomy Devices Market Research, 2031

The global neurothrombectomy devices market size was valued at $481.10 million in 2021, and is projected to reach $1.2 billion by 2031, growing at a CAGR of 9.5% from 2022 to 2031.

Neurothrombectomy is a surgical procedure in which blood clot is removed from blood vessel. A blood clot in the brain can cause an ischemic stroke, which is caused by an artery to the brain becoming blocked and starving a portion of the brain of oxygen and nutrients. A clot in the brain can further cause a buildup of cellular waste and carbon dioxide because the brain will be unable to clear this waste properly. This can cause the cells around the blockage to die, and the neurons in this portion of the brain to stop working, thus resulting in damage throughout the body. Neurothrombectomy is used to treat such acute ischemic strokes, which is associated with poor outcomes and high healthcare burden. According to the Centers for Disease Control and Prevention (CDC), 87.0% of all strokes reported in the U.S. are ischemic strokes. The first treatment of choice for ischemic stroke is mechanical thrombectomy, where a clot is removed mechanically by a specialist using clot retrievers or suction devices and thrombolytic therapy, in which medication is administered to dissolve the clot.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global neurothrombectomy devices market, as hospital visits and use of healthcare services for stroke treatment have significantly reduced due to the social distancing measures by government. The outbreak of COVID-19 directly impacted the development and manufacturing of neurothrombectomy devices, creating a disturbance in distribution in supply chain and increasing the financial burden of companies.

Neurothrombectomy Devices Market, Neurovascular Thrombectomy Devices Market, Neurothrombectomy Devices Market size, Neurothrombectomy Devices Market share, Neurothrombectomy Devices Market trends, Neurothrombectomy Devices Market growth, Neurothrombectomy Devices Market analysis, Neurothrombectomy Devices Market forecast, Neurothrombectomy Devices Market opportunity

Globally, the increasing adoption of these devices is due to the rising awareness and incidences of acute ischemic stroke along with the demand for minimally invasive procedures. For instance, according to the data published by the American Stroke Association, it was reported that more than 690,000 ischemic strokes are reported annually in the U.S. Moreover, increase in investments by market players in research and development of advanced devices and availability of reimbursement policies to cover treatment costs are some of the factors responsible for the growth of the market.

Also, owing to increase in incidence of ischemic stroke, the need to introduce advanced products in the market has escalated. Although the design and manufacturing of these devices are complicated, major players in the market are focusing on investing in research and development to launch innovative products. The development of new aspiration or suction devices, clot retrievers, and aspiration catheters based on advanced technology for ischemic stroke is driving the neurothrombectomy devices market growth. These latest devices are integrated with advanced features and offer distinct benefits such as high tracking ability, smooth retrieval, and easy usage. For instance, in October 2021, Phenox GmbH launched pRESET 6-50 mechanical thrombectomy devices globally to expand its technology for acute ischemic stroke. The product has the longest stent retriever in the phenox product portfolio. This addition of a long stent retriever helps in better patient outcomes and improved mortality rates.

Coronavirus (COVID-19) was discovered in late December in the Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. After its discovery in Wuhan, the disease has rapidly spread to other parts of the globe. This virus causes various symptoms in a patient; for instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement.

Furthermore, the virus has high potential of lethality in the geriatric population. On March 11, 2020, the World Health Organization assessed that COVID-19 can be characterized as a pandemic. Thus, social distancing was observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world adopted nationwide lockdown. Although the COVID-19 pandemic continues to impact the growth of various industries, and the immediate impact of the outbreak varies from industry to industry.

The neurothrombectomy devices market is segmented into Product Type and End User. On the basis of product type, the neurothrombectomy devices market size is classified into clot retrieval devices, aspiration devices, and snares. By end user, the market is fragmented into hospitals, specialty clinics, and others. Region wise, neurothrombectomy industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review

Neurothrombectomy devices Market

By product type, the clot retrieval devices generated maximum revenue in 2021, owing to rise in number of temporary as well as permanent blood clot surgeries. The aspiration devices segment is expected to witness highest CAGR during the forecast period, owing to increase in prevalence of ischemic stroke, significant improvement in clinical outcome with a good safety profile leading to increase in popularity of aspiration devices among healthcare professionals, and rise in awareness regarding neurothrombectomy devices among patients.

Neurothrombectomy devices Market

On the basis of end user, the hospitals segment generated maximum revenue in 2021, owing to increase in healthcare units, rise in number of patient admissions for surgery of blood clots in neurovascular region, and surge in venous thromboembolism cases. The specialty clinics segment is expected to witness highest CAGR during the forecast period, due to increase in trend experienced in particular treatment and rise in effectiveness of treatment given by specialty clinics.

Neurothrombectomy devices Market

North America captured largest neurothrombectomy devices market share in 2021, owing to increase in cases of ischemic strokes, robust healthcare infrastructure, presence of key players, and rise healthcare expenditure. However, Asia-Pacific is expected to witness highest CAGR during the neurothrombectomy devices market forecast, owing to rise in geriatric population, unmet medical demands, initiatives by government & non-governmental organizations (NGOs) to promote awareness regarding neurothrombectomy devices, and increase in public–private investments in the healthcare sector.

The key players that operate in the neurovascular thrombectomy devices market include, Acandis GmbH, Boston Scientific Corporation, Medtronic, Microvention Inc., Penumbra Inc., Phenox GmbH, Stryker Corporation, Teleflex, and Vesalio.          

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neurothrombectomy devices market analysis from 2021 to 2031 to identify the prevailing neurothrombectomy devices market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the neurothrombectomy devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global neurothrombectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Neurothrombectomy devices Market Report Highlights

Aspects Details
By Product Type
  • Clot Retrieval Devices
  • Aspiration Devices
  • Snares
By End User
  • Specialty Clinics
  • Hospitals
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Phenox GmbH, Vesalio, Teleflex Incorporated, Penumbra Inc., Boston Scientific Corporation, Acandis GmbH, MicroVention Inc., Medtronic, Stryker Corporation
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Clot Retrieval Devices

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Aspiration Devices

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Snares

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

  • CHAPTER 5: NEUROTHROMBECTOMY DEVICES MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Specialty Clinics

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Others

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: NEUROTHROMBECTOMY DEVICES MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Product Type

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Product Type
          • 6.2.4.1.2 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Product Type
          • 6.2.4.2.2 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Product Type
          • 6.2.4.3.2 Market size and forecast, by End User
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Product Type

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Product Type
          • 6.3.4.1.2 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Product Type
          • 6.3.4.2.2 Market size and forecast, by End User
        • 6.3.4.3 U.K.
          • 6.3.4.3.1 Market size and forecast, by Product Type
          • 6.3.4.3.2 Market size and forecast, by End User
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Market size and forecast, by Product Type
          • 6.3.4.4.2 Market size and forecast, by End User
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Market size and forecast, by Product Type
          • 6.3.4.5.2 Market size and forecast, by End User
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Product Type
          • 6.3.4.6.2 Market size and forecast, by End User
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Product Type

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Market size and forecast, by Product Type
          • 6.4.4.1.2 Market size and forecast, by End User
        • 6.4.4.2 China
          • 6.4.4.2.1 Market size and forecast, by Product Type
          • 6.4.4.2.2 Market size and forecast, by End User
        • 6.4.4.3 Australia
          • 6.4.4.3.1 Market size and forecast, by Product Type
          • 6.4.4.3.2 Market size and forecast, by End User
        • 6.4.4.4 India
          • 6.4.4.4.1 Market size and forecast, by Product Type
          • 6.4.4.4.2 Market size and forecast, by End User
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Market size and forecast, by Product Type
          • 6.4.4.5.2 Market size and forecast, by End User
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Market size and forecast, by Product Type
          • 6.4.4.6.2 Market size and forecast, by End User
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Product Type

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Product Type
          • 6.5.4.1.2 Market size and forecast, by End User
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Product Type
          • 6.5.4.2.2 Market size and forecast, by End User
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Market size and forecast, by Product Type
          • 6.5.4.3.2 Market size and forecast, by End User
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Market size and forecast, by Product Type
          • 6.5.4.4.2 Market size and forecast, by End User
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Medtronic

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Stryker Corporation

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Acandis GmbH

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Penumbra Inc.

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Phenox GmbH

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Vesalio

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 MicroVention Inc.

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Boston Scientific Corporation

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Teleflex Incorporated

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 2. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR CLOT RETRIEVAL DEVICES, BY REGION , 2021-2031,($MILLION)
    TABLE 3. NEUROTHROMBECTOMY DEVICES MARKET FOR CLOT RETRIEVAL DEVICES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 4. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR ASPIRATION DEVICES, BY REGION , 2021-2031,($MILLION)
    TABLE 5. NEUROTHROMBECTOMY DEVICES MARKET FOR ASPIRATION DEVICES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR SNARES, BY REGION , 2021-2031,($MILLION)
    TABLE 7. NEUROTHROMBECTOMY DEVICES MARKET FOR SNARES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 9. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
    TABLE 10. NEUROTHROMBECTOMY DEVICES MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 11. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2021-2031,($MILLION)
    TABLE 12. NEUROTHROMBECTOMY DEVICES MARKET FOR SPECIALTY CLINICS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 13. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
    TABLE 14. NEUROTHROMBECTOMY DEVICES MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 15. NEUROTHROMBECTOMY DEVICES MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 16. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 17. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 18. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 19. U.S. NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 20. U.S. NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 21. CANADA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 22. CANADA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 23. MEXICO NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 24. MEXICO NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 25. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 26. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 27. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 28. GERMANY NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 29. GERMANY NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 30. FRANCE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 31. FRANCE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 32. U.K. NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 33. U.K. NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 34. ITALY NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 35. ITALY NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 36. SPAIN NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 37. SPAIN NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 38. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 39. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 40. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 41. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 42. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 43. JAPAN NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 44. JAPAN NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 45. CHINA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 46. CHINA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 47. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 48. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 49. INDIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 50. INDIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 51. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 52. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 53. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 54. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 55. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 56. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 57. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 58. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 59. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 60. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 61. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 62. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 63. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 64. REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 65. REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 66.MEDTRONIC: COMPANY SNAPSHOT
    TABLE 67.MEDTRONIC: OPERATING SEGMENTS
    TABLE 68.MEDTRONIC: PRODUCT PORTFOLIO
    TABLE 69.MEDTRONIC: NET SALES,
    TABLE 70.MEDTRONIC: KEY STRATERGIES
    TABLE 71.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 72.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 73.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 74.STRYKER CORPORATION: NET SALES,
    TABLE 75.STRYKER CORPORATION: KEY STRATERGIES
    TABLE 76.ACANDIS GMBH: COMPANY SNAPSHOT
    TABLE 77.ACANDIS GMBH: OPERATING SEGMENTS
    TABLE 78.ACANDIS GMBH: PRODUCT PORTFOLIO
    TABLE 79.ACANDIS GMBH: NET SALES,
    TABLE 80.ACANDIS GMBH: KEY STRATERGIES
    TABLE 81.PENUMBRA INC.: COMPANY SNAPSHOT
    TABLE 82.PENUMBRA INC.: OPERATING SEGMENTS
    TABLE 83.PENUMBRA INC.: PRODUCT PORTFOLIO
    TABLE 84.PENUMBRA INC.: NET SALES,
    TABLE 85.PENUMBRA INC.: KEY STRATERGIES
    TABLE 86.PHENOX GMBH: COMPANY SNAPSHOT
    TABLE 87.PHENOX GMBH: OPERATING SEGMENTS
    TABLE 88.PHENOX GMBH: PRODUCT PORTFOLIO
    TABLE 89.PHENOX GMBH: NET SALES,
    TABLE 90.PHENOX GMBH: KEY STRATERGIES
    TABLE 91.VESALIO: COMPANY SNAPSHOT
    TABLE 92.VESALIO: OPERATING SEGMENTS
    TABLE 93.VESALIO: PRODUCT PORTFOLIO
    TABLE 94.VESALIO: NET SALES,
    TABLE 95.VESALIO: KEY STRATERGIES
    TABLE 96.MICROVENTION INC.: COMPANY SNAPSHOT
    TABLE 97.MICROVENTION INC.: OPERATING SEGMENTS
    TABLE 98.MICROVENTION INC.: PRODUCT PORTFOLIO
    TABLE 99.MICROVENTION INC.: NET SALES,
    TABLE 100.MICROVENTION INC.: KEY STRATERGIES
    TABLE 101.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 102.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 103.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 104.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 105.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 106.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
    TABLE 107.TELEFLEX INCORPORATED: OPERATING SEGMENTS
    TABLE 108.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
    TABLE 109.TELEFLEX INCORPORATED: NET SALES,
    TABLE 110.TELEFLEX INCORPORATED: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION
    FIGURE 2.NEUROTHROMBECTOMY DEVICES MARKET,2021-2031
    FIGURE 3.NEUROTHROMBECTOMY DEVICES MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.NEUROTHROMBECTOMY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.NEUROTHROMBECTOMY DEVICES MARKET,BY PRODUCT TYPE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CLOT RETRIEVAL DEVICES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ASPIRATION DEVICES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SNARES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 16.NEUROTHROMBECTOMY DEVICES MARKET,BY END USER,2021(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
    FIGURE 20.NEUROTHROMBECTOMY DEVICES MARKET BY REGION,2021
    FIGURE 21.U.S. NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 22.CANADA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 23.MEXICO NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 24.GERMANY NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 25.FRANCE NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 26.U.K. NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 27.ITALY NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 28.SPAIN NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 29.REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 30.JAPAN NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 31.CHINA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 32.AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 33.INDIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 34.SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 35.REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 36.BRAZIL NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 37.SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 38.SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 39.REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
    FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 44.COMPETITIVE DASHBOARD
    FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 46.MEDTRONIC.: NET SALES ,($MILLION)
    FIGURE 47.STRYKER CORPORATION.: NET SALES ,($MILLION)
    FIGURE 48.ACANDIS GMBH.: NET SALES ,($MILLION)
    FIGURE 49.PENUMBRA INC..: NET SALES ,($MILLION)
    FIGURE 50.PHENOX GMBH.: NET SALES ,($MILLION)
    FIGURE 51.VESALIO.: NET SALES ,($MILLION)
    FIGURE 52.MICROVENTION INC..: NET SALES ,($MILLION)
    FIGURE 53.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 54.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)

 
 

This section provides the opinions of the top level CXOs in the neurothrombectomy devices market. According to the insights of CXOs, neurothrombectomy devices are gaining high traction in the market, owing to increase incidence of venous thromboembolism and blood clots that lead to ischemic stroke, increase in investments for development of neurothrombectomy devices, and rise in awareness about neurothrombectomy devices and blockage in brain due to blood clot. Furthermore, key players in the market are focusing on adopting strategies to increase the accessibility and utilization of neurothrombectomy devices products in developing economies.

Furthermore, experts of key companies believe surge in geriatric population and increase in head injuries due to accidents & trauma cases are propelling the demand for treatment options. In addition, rise in cases of blood clot in the calf of adults may require temporary or permanent neurothrombectomy treatment, thus increasing the utilization of neurothrombectomy devices.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Rising awareness and incidences of acute ischemic stroke globally along with the demand for minimally invasive procedures are some of the driving factors of the market

A. Among product type, clot retrieval devices held dominant share of the neurothrombectomy devices market

A. North America is the largest regional market for Neurothrombectomy devices

A. The estimated market size of neurothrombectomy devices industry was $481.10 million in 2021

A. Medtronic, Penumbra Inc., and Stryker are top players operating in the neurothrombectomy market

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Neurothrombectomy Devices Market

Start reading instantly.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers